[1]
|
BrainCheck
|
|
NULL |
|
|
[2]
|
Ginkgolides and Huperzine A for complementary treatment of Alzheimer's disease
|
|
IUBMB …,
2022 |
|
|
[3]
|
Combined treatment with Ginkgo biloba extract EGb 761 plus acetylcholinesterase inhibitors improved cognitive function and neuropsychiatric symptoms in patients …
|
|
Alzheimer's & Dementia …,
2022 |
|
|
[4]
|
Leichte kognitive Beeinträchtigung (MCI) in der altersmedizinischen Praxis: Patientenorientierung, Diagnostik, Behandlung und Ethik
|
|
… für Gerontologie und …,
2022 |
|
|
[5]
|
A Single Dose of Ginkgo biloba Extract Induces Gene Expression of Hypothalamic Anorexigenic Effectors in Male Rats
|
|
Brain Sciences,
2021 |
|
|
[6]
|
Tratamiento con extracto de Ginkgo biloba (EGb761©) en adultos mayores con deterioro cognitivo: un estudio observacional
|
|
Anguita, C Cátedra, S Portela,
2021 |
|
|
[7]
|
Strategies for the use of Ginkgo biloba extract, EGb 761®, in the treatment and management of mild cognitive impairment in Asia: Expert consensus
|
|
2021 |
|
|
[8]
|
New therapeutic approaches to mild cognitive impairment and mild dementia: the role of Ginkgo Biloba (EGb 761®)
|
|
2021 |
|
|
[9]
|
Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761®)
|
|
2021 |
|
|
[10]
|
The use of Ginkgo biloba L. as a neuroprotective agent in the Alzheimer's disease
|
|
Brzezicka… - Frontiers in …,
2021 |
|
|
[11]
|
Management of mild cognitive impairment (MCI): The need for national and international guidelines
|
|
2020 |
|
|
[12]
|
Stability studies of hydralazine hydrochloride orodispersible formulations
|
|
2020 |
|
|
[13]
|
Prüfplan für die monozentrische prospektive randomisierte placebokontrollierte doppelblinde Phase-II-Studie zur Exploration protektiver Effekte des Ginkgo-biloba …
|
|
2020 |
|
|
[14]
|
Use of Herbal Products/Alternative Medicines in Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease)
|
|
Pathology, Prevention and Therapeutics of Neurodegenerative Disease,
2019 |
|
|
[15]
|
Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®
|
|
2019 |
|
|
[16]
|
Cognitive enhancement effect of Ginkgo biloba extract on memory and learning impairments induced by fluoride neurotoxicity
|
|
2019 |
|
|
[17]
|
Mitochondria-and Oxidative Stress-Targeting Substances in Cognitive Decline-Related Disorders: From Molecular Mechanisms to Clinical Evidence
|
|
2019 |
|
|
[18]
|
PLANT-DERIVED PHYTOCHEMICALS TO ENHANCE COGNITIVE FUNCTION AND ALERTNESS
|
|
2019 |
|
|
[19]
|
Cognitive impairment in anxiety disorders
|
|
2018 |
|
|
[20]
|
Přehled systematických souhrnů studií: využití extraktu z Ginkgo biloba v léčbě mírného kognitivního poškození a demence
|
|
2018 |
|
|
[21]
|
Phytochemicals for improving aspects of cognitive function and psychological state potentially relevant to sports performance
|
|
2018 |
|
|
[22]
|
Когнитивные нарушения при тревожных расстройствах
|
|
2018 |
|
|
[23]
|
Cognitive impairment without dementia: A current view of the problem
|
|
2017 |
|
|
[24]
|
Когнитивные жалобы и нарушения у пациентов с хронической ежедневной головной болью
|
|
2017 |
|
|
[25]
|
Cognitive complaints and cognitive impairment in patients with chronic daily headache
|
|
2017 |
|
|
[26]
|
Therapeutic efficacy of the Ginkgo special extract EGb761® within the framework of the mitochondrial cascade hypothesis of Alzheimer's disease
|
|
Mechanics of Advanced Materials and Structures,
2017 |
|
|
[27]
|
Недементные когнитивные нарушения: современный взгляд на проблему
|
|
2017 |
|
|
[28]
|
Лечение комбинированных когнитивных и эмоциональных расстройств у больных молодого и среднего возраста
|
|
2016 |
|
|
[29]
|
Effects of Ginkgo biloba extract EGb 761® on cognitive control functions, mental activity of the prefrontal cortex and stress reactivity in elderly adults with subjective memory impairment–a randomized double‐blind placebo‐controlled trial
|
|
Human Psychopharmacology: Clinical and Experimental,
2016 |
|
|
[30]
|
An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and Dementia
|
|
Frontiers in aging neuroscience,
2016 |
|
|
[31]
|
Treatment for mixed cognitive impairments and emotional disorders in young and middle-aged patients
|
|
2016 |
|
|
[32]
|
Bioactive dietary compounds regulate mitochondrial apoptosis signaling in ambivalent way to function as neuroprotective or antitumor agents
|
|
Studies in Natural Products Chemistry,
2016 |
|
|
[33]
|
Effects of Ginkgo biloba extract EGb 761® on cognitive control functions, mental activity of the prefrontal cortex and stress reactivity in elderly adults with subjective …
|
|
Human Psychopharmacology: Clinical and Experimental,
2016 |
|
|
[34]
|
Ginkgo biloba and Usage in Dementia: From Eastern Tradition to Western Science
|
|
Diet and Nutrition in Dementia and Cognitive Decline,
2015 |
|
|
[35]
|
A retrospective classification of diagnoses in terms of DSM-5 for patients included in randomized controlled trials of Ginkgo biloba extract EGb 761®
|
|
European archives of psychiatry and clinical neuroscience,
2015 |
|
|
[36]
|
Analysing time to event data in dementia prevention trials: The example of the guidage study of EGB761®
|
|
The journal of nutrition, health & aging,
2015 |
|
|
[37]
|
Efficacy and safety of Ginkgo biloba extract EGb 761? in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo‐controlled, double‐blind, multi‐center trial
|
|
International journal of geriatric psychiatry,
2014 |
|
|
[38]
|
Efficacy and safety of Ginkgo biloba extract EGb 761® in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo‐controlled …
|
|
International journal of geriatric psychiatry,
2014 |
|
|
[39]
|
Efficacy and safety of Ginkgo biloba extract EGb 761® in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo‐controlled, double‐blind …
|
|
2014 |
|
|
[40]
|
Ginkgo biloba Extract EGb 761?: From an Ancient Asian Plant to a Modern European Herbal Medicinal Product
|
|
Evidence and Rational Based Research on Chinese Drugs. Springer Vienna,
2013 |
|
|
[41]
|
Is Ginkgo biloba Safe?
|
|
life-enhancement,
2013 |
|
|
[42]
|
Применение мемопланта (EGb 761) в неврологической практике
|
|
МЕМОПЛАНТ В НЕВРОЛОГИИ,
2013 |
|
|
[43]
|
Ginkgo biloba leaf extract (EGb 761®) and its specific acylated flavonol constituents increase dopamine and acetylcholine levels in the rat …
|
|
International Psychogeriatrics,
2012 |
|
|
[44]
|
Ginkgo biloba leaf extract (EGb 761?) and its specific acylated flavonol constituents increase dopamine and acetylcholine levels in the rat medial prefrontal cortex: possible implications for the cognitive enhancing properties of EGb 761?
|
|
International Psychogeriatrics,
2012 |
|
|
[45]
|
Clinical data in early intervention
|
|
International Psychogeriatrics,
2012 |
|
|
[46]
|
Gait, mobility, and falls in older people
|
|
University Library of Basel,
2012 |
|
|
[47]
|
Ginkgo biloba leaf extract (EGb 761®) and its specific acylated flavonol constituents increase dopamine and acetylcholine levels in the rat medial prefrontal cortex …
|
|
2012 |
|
|
[48]
|
Ginkgo biloba leaf extract (EGb 761R ) and its speci?c acylated ?avonol constituents increase dopamine and acetylcholine levels in the rat medial prefrontal cortex: possible implications for the cognitive enhancing properties of EGb 761
|
|
International Psychogeriatrics,
2012 |
|
|
[49]
|
Frühe Intervention gefordert. Evidenz für Ginkgo biloba in der Demenz-Therapie
|
|
Schattauer,
2012 |
|
|